Rapport Therapeutics, Inc. (RAPP) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 9 sales totalling $7.5M. Most recent filing: Sept. 9, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 9, 2026 filed Sept. 8, 2026 | Ceesay Abraham Chief Executive Officer | −$374,498 | 8,210 | −2% | Yes | |
|
|
||||||
| Aug. 26, 2026 filed Aug. 25, 2026 | Ceesay Abraham Chief Executive Officer | −$937,957 | 18,921 | −4% | Yes | |
|
|
||||||
| Aug. 26, 2026 filed Aug. 24, 2026 | Yeleswaram Krishnaswamy Chief Development Officer | −$2,531,582 | 50,160 | −20% | Yes | |
|
|
||||||
| Aug. 20, 2026 filed Aug. 19, 2026 | Yeleswaram Krishnaswamy Chief Development Officer | −$20,160 | 404 | −0% | Yes | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Ceesay Abraham Chief Executive Officer | −$2,433,176 | 51,499 | −10% | Yes | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free